8JEN
Crystal structure of TIGIT in complexed with Ociperlimab, crystal form II
SAbDab Antibody Annotation SAbDab Database Homepage
Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
---|---|---|---|---|---|
A, C, E, K [auth G] | Heavy Chain | IGHV3 | - | t-cell immunoreceptor with ig and itim domains | SAbDab (2024-05-31) |
B, D, F, L [auth H] | Light Chain | IGKV3 | Kappa | t-cell immunoreceptor with ig and itim domains | SAbDab (2024-05-31) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
Chain | Name | Target | Provenance Source |
---|---|---|---|
A, C, E, K [auth G] | Ociperlimab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2024-05-31) |
B, D, F, L [auth H] | Ociperlimab | TIGIT/WUCAM/VSTM3 | Therapeutic SAbDab (2024-05-31) |
Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage
InterPro: Protein Family Classification InterPro Database Homepage
Pharos: Disease Associations Pharos Homepage Annotation
Chains | Drug Target   | Associated Disease |
---|---|---|
G [auth I], H [auth J], I [auth M], J [auth P] | Q495A1 | :